Target intelligence / Profile preview

Replication protein A 70 kDa DNA-binding subunit mRNA (RPA1 mRNA)

Target
RPA1 mRNA
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Replication protein A 70 kDa DNA-binding subunit (RPA1) mRNA encodes the largest subunit of the heterotrimeric RPA complex, which is the primary eukaryotic single-stranded DNA (ssDNA) binding protein. RPA1 is essential for nearly all aspects of DNA metabolism, including DNA replication, various DNA repair pathways such as nucleotide excision repair and homologous recombination, and the coordination of the DNA damage response. In many malignancies, RPA1 is significantly overexpressed to support the high proliferative demands and genomic stability of cancer cells, often correlating with poor clinical outcomes and resistance to DNA-damaging therapies. Targeting RPA1 mRNA using antisense oligonucleotides or RNA interference aims to deplete RPA1 protein levels, thereby inducing replication stress, inhibiting DNA repair, and sensitizing tumor cells to chemotherapy or radiation. While a promising strategy for precision oncology, the fundamental requirement of RPA1 for normal cellular division necessitates careful therapeutic window management to avoid systemic toxicity. Experimental studies have demonstrated that RPA1 knockdown can effectively suppress tumor growth and enhance the efficacy of DNA-damaging agents in various models, including hepatocellular carcinoma and glioblastoma.

Other names
Replication protein A1 mRNARPA70 mRNARF-A protein 1 mRNASingle-stranded DNA-binding protein mRNAREPA1 mRNA
02

Mechanism of action

Antisense inhibition or RNA interference (RNAi) to induce mRNA degradation, resulting in the depletion of RPA1 protein and subsequent disruption of DNA replication and repair.

03

Biological functions

DNA replicationDNA repairDNA recombinationDNA damage responseTelomere maintenanceReplication fork stabilization
04

Disease associations

CancerHepatocellular carcinomaBladder cancerLung cancerBreast cancerColon cancerGlioblastomaTelomere biology disorders
05

Safety considerations

Essentiality for normal cell division and genomic stabilityPotential for systemic toxicity in highly proliferative healthy tissues (e.g., bone marrow)Off-target effects of oligonucleotide-based therapiesInduction of unintended genomic instability
06

Biomarkers

RPA1 mRNA expression levelsRPA1 protein expressionGamma-H2AX (DNA damage marker)RAD51 foci formation

Beyond the preview

Go deeper on Replication protein A 70 kDa DNA-binding subunit mRNA (RPA1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Replication protein A 70 kDa DNA-binding subunit mRNA (RPA1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call